Orforglipron (CAS: 2212020-52-3)

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Orforglipron Type 2 Diabetes Eli Lilly and Company  Sep.26,2037


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us